Interleukin-1β induces interleukin-6 production through the production of prostaglandin E2 in human osteoblasts, MG-63 cells

被引:29
作者
Takaoka, Y [1 ]
Niwa, S [1 ]
Nagai, H [1 ]
机构
[1] Gifu Pharmaceut Univ, Dept Pharmacol, Gifu 5028585, Japan
关键词
EP-1; receptor; IL-1; beta; IL-6; PGE(2); osteoblasts;
D O I
10.1093/oxfordjournals.jbchem.a022485
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study was conducted to investigate the mechanism of interleukin-1 beta (IL-1 beta)-induced IL-6 production in human osteoblasts (MG-63 cells), Stimulation with IL-1 beta resulted in the production of IL-6 and prostaglandin E-2 (PGE(2)), IL-6 production gradually increased and peaked 96 h after stimulation. IL-6 mRNA was detected between 4 and 72 h after IL-1 beta stimulation. The patterns of PGE(2) production and the expression of cyclooxygenase-2 (COX-2) mRNA were biphasic after stimulation. Actinomycin D, cycloheximide, indomethacin, and NS-398 (COX-2 inhibitor) suppressed the production of IL-6 and PGE(2). Anti-PGE(2) antibody markedly reduced the production of IL-8, In addition, stimulation with 17-phenyl-PGE(2), a PGE receptor-1 (EP-1 receptor) agonist, led to the expression of IL-6 mRNA after pretreatment with IL-1 beta, These findings indicate that IL-1 beta-induced IL-8 production in MG-83 cells involves the following sequence of steps: IL-1 beta-induced COX-2 activation, PGE(2) production, and EP-1 receptor signaling prior to IL-6 production.
引用
收藏
页码:553 / 558
页数:6
相关论文
共 33 条
[1]  
Agro A, 1996, J RHEUMATOL, V23, P862
[2]   Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis [J].
Anderson, GD ;
Hauser, SD ;
McGarity, KL ;
Bremer, ME ;
Isakson, PC ;
Gregory, SA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2672-2679
[3]   NSAIDS inhibit the IL-1β-induced IL-6 release from human post-mortem astrocytes:: the involvement of prostaglandin E2 [J].
Blom, MAA ;
van Twillert, MGH ;
de Vries, SC ;
Engels, F ;
Finch, CE ;
Veerhuis, R ;
Eikelenboom, P .
BRAIN RESEARCH, 1997, 777 (1-2) :210-218
[4]  
CHIPLUNKAR S, 1986, J IMMUNOL, V137, P3748
[5]  
CRUSZAK CA, 1996, J CLIN PERIODONTOL, V23, P635
[6]  
DEWHIRST FE, 1985, J IMMUNOL, V135, P2562
[7]   INTERLEUKIN-1 [J].
DINARELLO, CA .
REVIEWS OF INFECTIOUS DISEASES, 1984, 6 (01) :51-95
[8]  
Fiebich BL, 1997, J NEUROCHEM, V68, P704
[9]   INTERLEUKIN-1 ACTIVITY IN THE SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
FONTANA, A ;
HENGARTNER, H ;
WEBER, E ;
FEHR, K ;
GROB, PJ ;
COHEN, G .
RHEUMATOLOGY INTERNATIONAL, 1982, 2 (02) :49-53
[10]   POTENTIATION OF T-LYMPHOCYTE RESPONSE TO MITOGENS .1. RESPONDING CELL [J].
GERY, I ;
GERSHON, RK ;
WAKSMAN, BH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (01) :128-&